{"hands_on_practices": [{"introduction": "The power of any scientific tool is matched by the rigor of the experiments in which it is used. In CRISPR-based gene editing, it is crucial to distinguish the effects of the intended gene knockout from unintended consequences of the experimental procedure itself. This practice asks you to think critically about experimental design by identifying the specific purpose of a non-targeting guide RNA, a fundamental control used to ensure that your results are valid and interpretable [@problem_id:1469656].", "problem": "A team of molecular biologists is investigating the function of a specific gene, `GeneA`, in a human cancer cell line. They hypothesize that `GeneA` is essential for cell proliferation. To test this, they employ the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 system to perform a knockout experiment.\n\nThe researchers set up two populations of cells that are treated as follows:\n\n-   **Population 1 (Experimental):** These cells are transfected with a plasmid that expresses both the Cas9 nuclease and a guide RNA (gRNA) designed to direct Cas9 to create a double-strand break within the `GeneA` locus, leading to its functional knockout.\n-   **Population 2 (Control):** These cells are transfected with a similar plasmid that expresses the Cas9 nuclease, but with a \"non-targeting\" gRNA. The sequence of this non-targeting gRNA is computationally designed to have no binding site anywhere in the human genome.\n\nThe researchers then measure the proliferation rate of both cell populations over several days. What is the primary reason for including Population 2 in this experimental design?\n\nA. To measure the efficiency of Homology-Directed Repair (HDR) versus Non-Homologous End Joining (NHEJ) after a double-strand break.\n\nB. To identify the specific locations in the genome where the `GeneA`-targeting gRNA may cause unintended, off-target cuts.\n\nC. To serve as a baseline for the natural rate of cell death and spontaneous mutation in the cell culture.\n\nD. To isolate and control for any potential cytotoxic or physiological effects caused by the introduction and expression of the Cas9 and gRNA components themselves, independent of DNA cleavage.\n\nE. To confirm that the plasmid containing the Cas9 and gRNA genes was successfully transfected into the cells.", "solution": "Define the experimental question: Does loss of GeneA reduce proliferation? The experimental manipulation in Population 1 is a Cas9 plus GeneA-targeting gRNA that induces double-strand breaks at the GeneA locus, leading to knockout. A proper control must match all components of the experimental condition except the specific genome cleavage at GeneA, so that any difference in proliferation can be attributed to loss of GeneA rather than to other factors such as transfection, Cas9 expression, gRNA expression, antibiotic selection, or cellular stress from the CRISPR machinery itself.\n\nA non-targeting gRNA lacks complementarity to the genome, so in Population 2 Cas9 and gRNA are expressed but do not induce specific DNA cleavage. Thus, Population 2 controls for any cytotoxic or physiological effects arising from the delivery and expression of Cas9 and gRNA and associated procedures, independent of on-target editing.\n\nEvaluate options:\n- A is incorrect because this setup does not compare HDR versus NHEJ; that would require a donor template and repair readouts.\n- B is incorrect because a non-targeting gRNA will not identify off-target sites; mapping off-targets requires assays like GUIDE-seq, CIRCLE-seq, or unbiased sequencing with the targeting gRNA.\n- C is incorrect because Population 2 is not a no-treatment baseline; it includes transfection and CRISPR component expression, so it does not measure the natural background death or mutation rate.\n- D is correct: it isolates effects due to Cas9/gRNA delivery and expression, independent of DNA cleavage.\n- E is not the primary purpose; transfection efficiency is typically confirmed with reporters or selection markers, not inferred from a non-targeting control.\n\nTherefore, the primary reason for including Population 2 is to control for the effects of Cas9 and gRNA expression and the transfection process, independent of target cleavage.", "answer": "$$\\boxed{D}$$", "id": "1469656"}, {"introduction": "The CRISPR toolkit is not a single hammer, but a versatile set of precision instruments, and choosing the right one is key to a successful experiment. While a gene 'knockout' is a common goal, what happens when the gene is essential for life? This thought experiment demonstrates why the standard CRISPR-Cas9 nuclease is not always the best choice and introduces CRISPR interference (CRISPRi) as an elegant solution to study essential genes by 'knocking down' their expression instead of eliminating them completely [@problem_id:1469662].", "problem": "A geneticist is studying a gene, *ESS1*, which is hypothesized to be essential for the viability of a specific line of cultured human cells. The researcher's goal is to investigate the cellular phenotypes that arise from a *reduction* in the expression of *ESS1*, rather than its complete elimination. To do this, they can use one of two technologies derived from the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system:\n\n1.  **CRISPR-Cas9 Knockout**: This standard method uses the Cas9 nuclease to create a permanent, heritable disruption (a 'knockout') of the *ESS1* gene by introducing small insertions or deletions in its DNA sequence, typically leading to a non-functional protein.\n2.  **CRISPR interference (CRISPRi)**: This method uses a catalytically deactivated Cas9 protein (dCas9) fused to a transcriptional repressor. The dCas9-repressor complex is guided to the *ESS1* promoter but does not cut the DNA. Instead, it physically blocks transcription, leading to a temporary and tunable decrease in gene expression (a 'knockdown').\n\nWhich of the following statements provides the most critical scientific reason for choosing the CRISPRi system over the CRISPR-Cas9 knockout system for this particular experiment?\n\nA. The CRISPRi system is generally faster to implement and requires less complex plasmid constructs.\n\nB. The CRISPR-Cas9 knockout system creates permanent genetic changes, which are ethically impermissible in human cell lines.\n\nC. A complete and permanent knockout of an essential gene would lead to cell death, making it impossible to culture and study the cells to observe the desired phenotypes.\n\nD. The CRISPRi system has been proven to have zero off-target effects, unlike the CRISPR-Cas9 knockout system which is known to be error-prone.\n\nE. The CRISPR-Cas9 knockout system can only target genes in the cytoplasm, whereas CRISPRi is required to target genes within the nucleus.", "solution": "The problem asks for the primary scientific rationale for using CRISPR interference (CRISPRi) instead of a standard CRISPR-Cas9 knockout to study an essential gene. The key is in the definition of an \"essential gene\" and the goal of the experiment, which is to study the effects of *reduced* expression, not complete loss.\n\n1.  **Analyze the nature of the target gene:** The gene *ESS1* is described as essential for cell viability. This means that if the gene is completely non-functional, the cell cannot survive.\n\n2.  **Analyze the effect of the CRISPR-Cas9 Knockout system:** This system creates a permanent, null mutation (a knockout). If applied to an essential gene like *ESS1*, the resulting loss of function will be lethal to the cells. The cells would undergo apoptosis or fail to proliferate. Consequently, the researcher would have no surviving cells to analyze, and the experiment to study the phenotypes of reduced function would fail entirely.\n\n3.  **Analyze the effect of the CRISPRi system:** This system causes gene knockdown, meaning it reduces the amount of transcription from the target gene without altering the DNA sequence. This effect is dose-dependent and reversible. By reducing the expression of *ESS1* instead of eliminating it, the cells may remain viable but exhibit specific phenotypes related to the partial loss of function. This allows the researcher to study the consequences of having lower-than-normal levels of the *ESS1* protein, which directly aligns with the stated experimental goal.\n\n4.  **Evaluate the given options:**\n    *   **A:** While practical considerations like speed or cost can influence experimental design, they are not the fundamental *scientific* reason for the choice. The primary reason must be based on the biological feasibility of the experiment.\n    *   **B:** This statement is incorrect. Using CRISPR to create permanent genetic modifications in cultured human cell lines for research purposes is a standard, ethically permissible, and widespread practice. Ethical concerns are primarily focused on germline editing in human embryos.\n    *   **C:** This statement correctly identifies the central issue. A knockout of an essential gene is lethal, preventing any downstream analysis. CRISPRi provides a non-lethal alternative (knockdown) that allows for the study of dose-dependent effects of an essential gene's function. This is the most critical scientific reason for the choice.\n    *   **D:** This statement is an oversimplification and factually incorrect. Both CRISPR-Cas9 and CRISPRi systems can have off-target effects, which depend on the specificity of the guide RNA. While the profiles may differ, it is not true that CRISPRi is perfectly specific or that knockout is uniquely error-prone. The primary motivation here is not off-target avoidance but on-target lethality.\n    *   **E:** This statement is incorrect. Both CRISPR-Cas9 and CRISPRi systems are designed to function in the nucleus, where the cell's genomic DNA is located, as that is where transcription and gene editing occur.\n\nTherefore, the only valid and critical reason for choosing CRISPRi in this context is to avoid the lethal outcome of a full knockout of an essential gene.", "answer": "$$\\boxed{C}$$", "id": "1469662"}, {"introduction": "Beyond editing single genes, CRISPR-Cas9 enables scientists to model complex diseases by engineering large-scale changes to the genome, such as the chromosomal translocations that drive many cancers. This exercise challenges you to plan such an experiment, recreating the cancer-associated translocation t(14;18) in the lab. You will step into the role of a researcher, using a series of real-world efficiencies to calculate the expected outcome and appreciate the quantitative planning required to successfully engineer a disease model [@problem_id:1469671].", "problem": "A team of researchers is developing an in-vitro model for follicular lymphoma, a type of cancer characterized by a specific chromosomal translocation, t(14;18). This translocation juxtaposes the B-cell lymphoma 2 (*BCL2*) gene from chromosome 18 with the enhancer elements of the immunoglobulin heavy chain (*IGH*) locus on chromosome 14, leading to the overexpression of the anti-apoptotic BCL2 protein.\n\nTo generate this translocation, the researchers will use a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 system with a dual-single-guide RNA (dsgRNA) plasmid. One guide RNA targets the *IGH* locus on chromosome 14, and the other targets the *BCL2* gene on chromosome 18. The simultaneous creation of double-strand breaks (DSBs) at both loci can, through the cell's repair mechanisms, result in the desired t(14;18) translocation.\n\nThe experiment is conducted under the following conditions:\n- The initial population of cultured human B-cells is $5.00 \\times 10^{6}$.\n- The efficiency of transfecting the cells with the CRISPR-Cas9/dsgRNA plasmid is 60.0%. Only transfected cells are capable of undergoing gene editing.\n- The cutting efficiency of the gRNA targeting the *IGH* locus (chromosome 14) is 85.0%. This is the probability that a DSB is successfully created at this site in a transfected cell.\n- The cutting efficiency of the gRNA targeting the *BCL2* locus (chromosome 18) is 75.0%. This is the probability that a DSB is successfully created at this site in a transfected cell. The two cutting events are independent.\n- If DSBs are successfully created at both loci within the same cell, there is a 4.00% probability that the cellular repair machinery will produce the specific t(14;18) translocation. Other outcomes include independent repair of the breaks or other chromosomal aberrations.\n- After the editing procedure, the entire cell population is plated under conditions that allow single cells to grow into distinct colonies. The overall cloning efficiency, which is the fraction of cells that survive the entire process and successfully form a colony, is 15.0%.\n\nCalculate the expected number of cell colonies that will harbor the desired t(14;18) translocation. Provide your answer as an integer.", "solution": "Let $N_{0}$ be the initial number of cells, $p_{\\text{transfect}}$ the transfection efficiency, $p_{14}$ the cutting efficiency at the $IGH$ locus (chromosome 14), $p_{18}$ the cutting efficiency at the $BCL2$ locus (chromosome 18), $p_{\\text{transloc}|\\text{both}}$ the probability that a cell with double-strand breaks at both loci forms the specific translocation, and $p_{\\text{clone}}$ the cloning efficiency.\n\nOnly transfected cells can be edited. The two cuts are independent, so the probability that both cuts occur in a transfected cell is $p_{14}p_{18}$. Given both cuts occur, the probability of forming the desired translocation is $p_{\\text{transloc}|\\text{both}}$. Therefore, the probability that a randomly chosen initial cell yields the desired translocation is\n$$\np_{\\text{transloc}}=p_{\\text{transfect}}\\,p_{14}\\,p_{18}\\,p_{\\text{transloc}|\\text{both}}.\n$$\nThe expected number of such cells that also form colonies is then\n$$\nN_{\\text{colonies}}=N_{0}\\,p_{\\text{transfect}}\\,p_{14}\\,p_{18}\\,p_{\\text{transloc}|\\text{both}}\\,p_{\\text{clone}}.\n$$\nSubstituting the given values $N_{0}=5.00 \\times 10^{6}$, $p_{\\text{transfect}}=0.600$, $p_{14}=0.850$, $p_{18}=0.750$, $p_{\\text{transloc}|\\text{both}}=0.040$, and $p_{\\text{clone}}=0.150$, we compute step by step:\n$$\n0.600 \\times 0.850=0.510,\\quad 0.510 \\times 0.750=0.3825,\\quad 0.3825 \\times 0.040=0.0153,\\quad 0.0153 \\times 0.150=0.002295,\n$$\nso\n$$\nN_{\\text{colonies}}=(5.00 \\times 10^{6})\\times 0.002295=11475.\n$$\nThus, the expected number of colonies harboring the t(14;18) translocation is $11475$.", "answer": "$$\\boxed{11475}$$", "id": "1469671"}]}